Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Brain Ischemia

eicosapentaenoic acid ethyl ester has been researched along with Brain Ischemia in 2 studies

Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dron, JS1
Hegele, RA1
Katsumata, T1
Katayama, Y1
Obo, R1
Muramatsu, H1
Ohtori, T1
Terashi, A1

Other Studies

2 other studies available for eicosapentaenoic acid ethyl ester and Brain Ischemia

ArticleYear
Ischemic Event Reduction and Triglycerides.
    Journal of the American College of Cardiology, 2019, 10-08, Volume: 74, Issue:14

    Topics: Brain Ischemia; Eicosapentaenoic Acid; Humans; Stroke; Triglycerides

2019
Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model.
    European journal of pharmacology, 1999, May-14, Volume: 372, Issue:2

    Topics: Animals; Autoradiography; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Delayed-

1999